ZR2 BIOENERGY LIMITED (ZR2)

BSE: ₹150.00
Stock Performance
Corporate Announcements
Audited Financial Results For The Quarter Ended 31St March, 2026

This is to inform that the Board of Directors, at its meeting held today i.e. Friday, May 29, 2026 inter-alia have considered and approved the following: 1. Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2026.

2026-05-29 18:55:02
Board Meeting Outcome for Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Year Ended March 31, 2026.

This is to inform that the Board of Directors, at its meeting held today i.e. Friday, May 29, 2026 inter-alia have considered and approved the following: 1. Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended March 31, 2026.

2026-05-29 18:40:45
Clarification Sought From The Company On Significant Movement In Price

The Exchange has sought clarification from ZR2 Bioenergy Limited with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.

2026-05-28 17:38:14
Clarification Sought From The Company On Significant Movement In Price

The Exchange has sought clarification from ZR2 Bioenergy Limited with reference to significant movement in price, in order to ensure that investors have latest relevant information about the company and to inform the market so that the interest of the investors is safeguarded.

2026-05-28 17:33:32
Board Meeting Intimation for Intimation Of 01/2026-27 Board Meeting For Consideration Of Audited Financial Results For The Quarter Ended March 31, 2026.

In compliance with Regulation 29 and other applicable provisions of LODR Regulations, this is to inform that 01/2026-27 meeting of the Board of Directors of the Company is scheduled to be held on Friday, May 29, 2026, to consider and approve the Audited Financial Results (Standalone and Consolidated) of the Company for the quarter and financial year ended March 31, 2026

2026-05-26 16:48:12
Announcement under Regulation 30 (LODR)-Monitoring Agency Report

MONITORING AGENCY REPORT FOR THE QUARTER ENDED 31ST MARCH, 2026

2026-05-15 21:45:13
Closure of Trading Window

Dear Sir/Madam, We write to inform you that in accordance with the Company’s Code of Conduct for Insider Trading (“Code”) read with applicable provisions of SEBI (Prohibition of Insider Trading) Regulation, 2015, the Trading Window for dealing in securities of the Company by Designated Persons and their immediate relatives shall remain closed with effect from April 01, 2026 till 48 hours after the approval and dissemination of Audited Financial Results for the quarter and financial year ended March 31, 2026 to the Stock Exchanges.

2026-04-19 17:49:05
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Dear Sir/Madam, Pursuant to Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018, please find enclosed herewith a confirmation certificate received from MUFG Intime India Private Limited the Registrar and Transfer Agent of the Company for quarter ended March 31, 2026. Please take the above on record.

2026-04-13 21:47:43

Quarterly Financials

Consolidated Standalone
Particulars Sep 2022 Dec 2022 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
YOY Revenue Growth % - - - - - - - -
Other Income 0.05 0.06 0.03 0.45 0.46 0.55 0.42 0.44
Total Income 0.05 0.06 0.03 0.45 0.46 0.55 0.42 0.44
Total Expenses + 0.06 0.09 0.58 0.22 0.16 0.28 0.22 0.24
Cost of Materials Consumed 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Employee Benefit Expense 0.02 0.04 0.19 0.07 0.07 0.09 0.03 0.02
Other Expenses 0.04 0.05 0.38 0.13 0.07 0.05 0.04 0.20
Operating Profit -0.06 -0.09 -0.58 -0.22 -0.16 -0.28 -0.22 -0.24
OPM % 0% 0% 0% 0% 0% 0% 0% 0%
Profit Before Tax + -0.01 -0.03 -0.55 0.22 0.30 0.27 0.20 0.20
Tax Expense 0.00 0.00 0.00 0.11 0.00 0.00 -0.03 0.00
Tax % - - - 49.7% -0.3% 0.9% -15.7% -0.6%
Profit After Tax -0.01 -0.03 -0.55 0.11 0.31 0.27 0.23 0.20
EPS (Basic) -0.04 -0.19 -1.54 0.32 0.86 0.76 0.64 0.56

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026 Mar 2025
Revenue from Operations 0.00 1.49
YOY Revenue Growth % -100% -
Other Income 1.87 0.64
Total Income 1.87 2.14
Total Expenses + 0.89 1.94
Employee Benefit Expense 0.20 0.18
Other Expenses 0.36 0.45
Operating Profit -0.89 -0.44
OPM % 0% -29.5%
Profit Before Exceptional 0.97 0.20
Exceptional Items 0.00 0.00
Profit Before Tax + 0.97 0.20
Tax Expense -0.03 0.11
Tax % -3.1% 55.3%
Profit After Tax 1.00 0.09
EPS (Basic) 2.81 0.25

Balance Sheet

Particulars Mar 2026 Mar 2025
ASSETS
Non-Current Assets + 120.64 119.59
Property, Plant & Equipment 0.30 0.50
Capital Work in Progress 120.17 118.96
Non-Current Investments 0.00 0.00
Goodwill 0.00 0.00
Other Intangible Assets 0.00 0.00
Current Assets + 20.66 19.91
Inventories 0.00 0.00
Trade Receivables 0.00 0.02
Cash and Cash Equivalents 18.84 19.09
Current Investments 0.00 0.00
LIABILITIES & EQUITY
Total Equity 139.97 139.34
Equity Share Capital 0.36 0.36
Other Equity 139.61 138.99
Non-Current Liabilities 0.00 0.09
Current Liabilities 1.34 0.07
Total Liabilities 1.34 0.16

Cash Flow Statement

Particulars Mar 2026 Mar 2025
Cash from Operating Activities -0.69 31.05
Cash from Investing Activities 0.48 -116.66
Cash from Financing Activities -0.04 100.39
Net Increase/Decrease in Cash -0.25 14.78